Type of diabetes-Type 2 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

Do SGLT2 inhibitors reduce heart disease compared to DPP-4 inhibitors?

Do SGLT2 inhibitors reduce heart disease compared to DPP-4 inhibitors?

Posted by on Jul 26, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects on heart disease for SGLT2 inhibitors vs DPP-4 inhibitors in patients with type 2 diabetes (T2D). It found that patients using SGLT2 inhibitor medications had lower rates of heart failure, heart attack, and stroke. Some background T2D is a disorder of high levels of glucose (sugar) in the blood. T2D...

Read More

Does testosterone treatment improve diabetes control in men with type 2 diabetes and low testosterone?

Does testosterone treatment improve diabetes control in men with type 2 diabetes and low testosterone?

Posted by on Jul 26, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at adding testosterone undecanoate (Aveed) to standard therapy for men with type 2 diabetes (T2D) and low testosterone levels. It found that men treated with testosterone had better long-term outcomes and that a third of patients achieved remission from diabetes. Some background T2D is a metabolic disorder in which the...

Read More

Can iGlarLixi improve blood glucose control in patients receiving basal insulin?

Can iGlarLixi improve blood glucose control in patients receiving basal insulin?

Posted by on May 24, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at whether iGlarLixi (Soliqua), a combination of long-acting insulin glargine (Lantus) and lixisenatide (Lyxumia), can improve glucose control for patients with type 2 diabetes (T2D) uncontrolled with long-acting insulin alone. It found that iGlarLixi improved overall and after-meal blood sugar control compared to insulin...

Read More

Can a non-insulin drug improve treatment results for patients with uncontrolled type 2 diabetes taking insulin?

Posted by on May 6, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined if non-insulin drug lixisenatide (Lyxumia) boosted treatment results from insulin glargine (Lantus) in patients with uncontrolled type 2 diabetes (T2D). Patients who received lixisenatide and glargine had improved blood glucose control and no significant increase in side effects. Some background Uncontrolled...

Read More

How effective are two non-insulin drugs when used in combination to treat patients with type 2 diabetes?

Posted by on Apr 5, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and safety of two types of non-insulin drugs used in combination to treat patients with uncontrolled type 2 diabetes (T2D). The results showed that the drug combination effectively reduced patients’ blood glucose levels and body weight and did not cause serious side effects. Some background...

Read More

Which insulin is better for reducing blood glucose levels before hypoglycemia occurs?

Posted by on Mar 28, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared two insulin types – degludec (Tresiba) and glargine (Lantus) – to see which was better at reducing blood glucose levels before hypoglycemia (dangerously low blood glucose levels) occurred. The study found that degludec improved blood glucose levels for longer than glargine before patients experienced...

Read More

Does dapagliflozin protect kidney function in patients with diabetes?

Posted by on Dec 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the effect of dapagliflozin (Farxiga) on kidney disease in patients with type 2 diabetes. It found patients treated with dapagliflozin were significantly less likely to have a decline in kidney function. Some background In type 2 diabetes (T2D), the body no longer regulates blood sugar well. If blood sugar is not...

Read More

Evaluating risk of low blood sugar in patients with diabetes taking insulin degludec

Posted by on Dec 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of switching to insulin degludec (Tresiba) in patients with diabetes mellitus. This study concluded that patients had better blood glucose control and a lower risk of low blood sugar after switching. Some background Insulin therapy is the typical first-line treatment for patients...

Read More